Serena Mraz, MD
Dermatology · Vallejo, CANPI 1518911395
Payments from drug & device makers
Across 915 payments — averaging $738.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$301K
- AbbVie$207K
- Janssen Research & Development, LLC$125K
- Novartis$34K
- E.r. Squibb & Sons, L.L.C.$3K
- Helsinn Therapeutics (U.S.), Inc.$1K
- plus $5K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 333 | $301,024 |
| AbbVie(2 entities) | 291 | $206,603 |
| Janssen Research & Development, LLC | 27 | $124,681 |
| Novartis | 85 | $34,085 |
| E.r. Squibb & Sons, L.L.C. | 12 | $3,012 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $1,482 |
| Johnson & Johnson | 64 | $996 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 12 | $623 |
| Sanofi | 17 | $554 |
| Janssen Scientific Affairs, LLC | 5 | $428 |
| Pfizer | 14 | $273 |
| Amgen | 6 | $238 |
| Sun Pharmaceutical Industries Inc. | 4 | $233 |
| Modernatx, Inc. | 1 | $188 |
| UCB, Inc. | 6 | $177 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $132 |
| Lilly USA, LLC | 6 | $121 |
| Arcutis Biotherapeutics, Inc. | 5 | $92 |
| Fresenius Kabi USA, LLC | 3 | $87 |
| Regeneron Healthcare Solutions, Inc. | 4 | $82 |
| Strata Skin Sciences, Inc. | 1 | $57 |
| LEO Pharma Inc. | 3 | $54 |
| Incyte Corporation | 3 | $50 |
| Revance Therapeutics, Inc. | 2 | $46 |
| Merz North America, Inc. | 2 | $44 |
| Bristol Myers Squibb | 2 | $42 |
| Osiris Therapeutics Inc. | 1 | $29 |
| Sandoz | 1 | $24 |
| Dermavant Sciences, Inc. | 1 | $19 |
| Boston Scientific | 1 | $15 |
How this compares
$675,489 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Vallejo
- Paradi MirmiraniVallejo$2M
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Raja SivamaniSacramento$11.8M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
- Navid EzraThousand Oaks$7.8M
- Paul WallaceBeverly Hills$7.1M
- April ArmstrongLos Angeles$6.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.